Dermal filler of cross-linked hyaluronic acid at a concentration of 20 mg/ml.
1 x 1-ml syringe
Pairs well with
Adding product to your cart
-
About mesofiller® global 20 mg/ml
Dermal filler of cross-linked hyaluronic acid at a concentration of 20 mg/ml. Its specific rheological profile provides a medium elasticity and viscous component filler which allows an increase of volume of low stiffness for greater naturalness in areas exposed to continuous face muscle movement such as lips and glabella.
-
- -
-
Brand mesofiller® Product category dermal filler solutions Age all Routine stage treatment Type of skin - all
Indication mesofiller® is a new range of fillers containing top-quality crosslinked hyaluronic acid. Monophasic (containing no free hyaluronic acid) gel of non-animal origin, it is fully resorbed and blends into the skin perfectly. The mesofiller® range is based on DENSIMATRIX® technology. A process enabling uniform crosslinking of 100% of hyaluronic acid chains, which allows greater durability and better resistance to degradation. Hyaluronic acid is subjected to a purification process which helps reduce residual BDDE (butanediol diglycidyl ether) levels to a minimum, guaranteeing maximum purity (the residual BDDE content is less than 0,05 parts per million). The low level of residual BDDE ensures lower toxicity, minimizing the risk of intolerance and side effects. Treatment area - face
-
TREATMENT AREA - face
FREQUENCY OF USE - TIME OF USE -
🕓 -, -.
-
About mesofiller® global 20 mg/ml
Dermal filler of cross-linked hyaluronic acid at a concentration of 20 mg/ml. Its specific rheological profile provides a medium elasticity and viscous component filler which allows an increase of volume of low stiffness for greater naturalness in areas exposed to continuous face muscle movement such as lips and glabella.
- -
Brand | mesofiller® |
---|---|
Product category | dermal filler solutions |
Age | all |
Routine stage | treatment |
Type of skin |
|
Indication | mesofiller® is a new range of fillers containing top-quality crosslinked hyaluronic acid. Monophasic (containing no free hyaluronic acid) gel of non-animal origin, it is fully resorbed and blends into the skin perfectly. The mesofiller® range is based on DENSIMATRIX® technology. A process enabling uniform crosslinking of 100% of hyaluronic acid chains, which allows greater durability and better resistance to degradation. Hyaluronic acid is subjected to a purification process which helps reduce residual BDDE (butanediol diglycidyl ether) levels to a minimum, guaranteeing maximum purity (the residual BDDE content is less than 0,05 parts per million). The low level of residual BDDE ensures lower toxicity, minimizing the risk of intolerance and side effects. |
Treatment area |
|
TREATMENT AREA |
|
FREQUENCY OF USE | - |
TIME OF USE | - |
🕓 -, -.
-